Drug Price Regulation, B.C. Reg. 344/2012
Section 9
Maximum payment for non-reference drugs
Cite as Drug Price Regulation, B.C. Reg. 344/2012, s. 9 · last amended March 1, 2026 · read from BC Laws on November 17, 2026
The text
(1) The maximum amount the minister may pay for a non-reference drug that is not subject to the LCA program is the lesser of
(a) the sum of the manufacturer's list price for the drug and 8% of that price, and
(b) the maximum daily amount the minister may pay for the reference drug comparator for the reference drug category to which the non-reference drug belongs, as if the reference drug comparator were being dispensed at the daily therapeutic dose determined under section 6 (5) [reference drug program].
(2) The maximum amount the minister may pay for a non-reference drug that is subject to the LCA program is the lesser of
(a) the amount determined under subsection (1), as if the non-reference drug were not subject to the LCA program, and
(b) either,
(i) if there are no provisional drugs in the LCA category to which the non-reference drug belongs, the sum of the maximum accepted list price for the LCA category to which the drug belongs and 8% of that price, or
(ii) if there are provisional drugs in the LCA category to which the non-reference drug belongs, the maximum amount the minister may pay for a drug under section 11 (4) [prices for other drugs].
Read the Drug Price Regulation on BC Laws ↗
Made under Pharmaceutical Services Act, SBC 2012, c. 22.